Albatira, Baby Boy T.

HRN: 21-26-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
AMPICILLIN 250MG (VIAL)
05/18/2022
05/25/2022
IVT
180 Mg
12 Hrs
Meconium Aspiration Syndrome
Waiting Final Action 
05/18/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/18/2022
05/25/2022
IVT
18 Mg
24 Hrs
Meconium Aspiration Syndrome
Waiting Final Action 
05/23/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/23/2022
05/30/2022
IV
36mg
Q8h
NEC
Waiting Final Action 
05/23/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/23/2022
05/29/2022
IV
360mg
Q8hrs
Sepsis
Waiting Final Action 
05/23/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/23/2022
05/29/2022
IV
54mg
Q24hrs
Sepsis
Waiting Final Action 
05/30/2022
CEFTAZIDIME 1GM (VIAL)
05/30/2022
06/06/2022
IV
180mg
Q8
Cns Infection, Sepsis Neonatorum
Waiting Final Action 
06/01/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/01/2022
06/07/2022
ORAL
0.9ml Day1, 0.5 Ml Thereafter
Od
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: